Register
Forgot your password?

Syncope: etiology, pathophysiology, diagnosisand treatment (based on the recommendationsof the american and european societies of cardiology)

Authors: B.Sh. Berdibekov

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

For correspondence:  Sign in or register.


DOI: https://doi.org/10.24022/1997-3187-2017-11-4-361-375

For citation: Berdibekov B.Sh. Syncope: etiology, pathophysiology, diagnosis and treatment (based on the recommendations of the American and European societies of cardiology). Kreativnaya Kardiologiya (Creative Cardiology). 2017; 11 (4): 361–75 (in Russ.). DOI: 10.24022/1997-3187-2017-11-4-361-375

Received / Accepted:  05.07.2017/28.07.2017

Keywords: syncope etiology pathogenesis recommendations

Download
Full text:  

 

Abstract

Syncope is a condition that is characterized as an attack of loss of consciousness due to a brief decrease in cerebral perfusion pressure beyond the range of autoregulation of cerebral blood flow, which leads to short-term global hypoperfusion of the brain. In this article current state of knowledge on etiology, diagnosis, management, and therapy of syncope by the American College of Cardiology.

References

  1. Shen W.K., Sheldon R.S., Benditt D.G. et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2017: 4–59. DOI:10.1161/CIR. 0000000000000499.

  2. Moya A., Sutton R., Ammirati F. et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur. Heart J. 2009; 2631–71. DOI: 10.1093/eurheartj/ehp298.

  3. Амoсов Н.М., Бендет Я.А. Физическая активность и сердце. 3-е изд. Киев: Здоровья; 1989 / Amosov NM, Physical activity and heart / Amosov N.M., Bendet Ya.A. 3rd ed. Kiev: Zdorov'ya; 1989 (in Russ.).

  4. Cipolla M.J. The Cerebral Circulation. University of Vermont College of Medicine San Rafael (CA): Morgan & Claypool Life Sciences. J. Cerebr. Circ. 2009 (5): 29–30.

  5. Ku D.N., Zhu C. In: Sumpio B.E. (Ed.) Hemodynamic forces and vascular cell biology. Austin: CRC Press, RG Landes Co.; 1993.

  6. Oshorov A.V., Goryachev A.S., Popugaev K.A. et al. Monitoring cerebral perfusion pressure in intensive care. Bull. Anesthesiol. Reanimatol. 2013; 10 (2): 2–24.

  7. Paulson O.B., Strandgaard S., Edvinsson L. Cerebral autoregulation. Cerebrovasc. Brain. Metab. Rev. 1990; 2: 161–92.

  8. Osol G., Brekke J.F., McElroy-Yaggy K., Gokina N.I. Myogenic tone, reactivity, and forced dilatation: a three-phase model of in vitro arterial myogenic behavior. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: 2260–7.

  9. Mellander S. Functional aspects of myogenic vascular control. J. Hypertens. 1989; 7: 21–30.

  10. Berecki-Gisolf J., Sheldon A., Wieling W. et al. Identifying cardiac syncope based on clinical history: a literature-based model tested in four independent datasets. PLoS ONE. 2013; 8: 752–55.

  11. Derose S.F., Gabayan G.Z., Chiu V.Y. et al. Patterns and preexisting risk factors of 30-day mortality after a primary discharge diagnosis of syncope or near syncope. Acad. Emerg. Med. 2012; 19: 488–96.

  12. D’Ascenzo F., Biondi-Zoccai G., Reed M.J. et al. Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the emergency department with syncope: an international metaanalysis. Int. J. Cardiol. 2013; 167: 57–62.

  13. Grossman S.A., Fischer C., Lipsitz L.A. et al. Predicting adverse outcomes in syncope. J. Emerg. Med. 2007; 33: 233–9.

  14. Gabayan G.Z., Derose S.F, Asch S.M. et al. Predictors of short-term (seven-day) cardiac outcomes after emergency department visit for syncope. Am. J. Cardiol. 2010; 105: 82–6.

  15. Martin T.P., Hanusa B.H., Kapoor W.N. Risk stratification of patients with syncope. Ann. Emerg. Med. 1997; 29: 459–66.

  16. Sule S., Palaniswamy C., Aronow W.S. et al. Etiology of syncope in patients hospitalized with syncope and predictors of mortality and rehospitalization for syncope at 27-month follow-up. Clin. Cardiol. 2011; 34: 35–8.

  17. Douglas P.S., Garcia M.J., Haines D.E. et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SC CM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J. Am. Coll. Cardiol. 2011; 57: 1126–66.

  18. Subbiah R., Chia P.L., Gula L.J. et al. Cardiac monitoring in patients with syncope: making that elusive diagnosis. Curr. Cardiol. Rev. 2013; 9: 299–307.

  19. Krahn A.D., Klein G.J., Yee R. et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001; 104: 46–51.

  20. Linker N.J., Voulgaraki D., Garutti C. et al. Early versus delayed implantation of a loop recorder in patients with unexplained syncope–effects on care pathway and diagnostic yield. Int. J. Cardiol. 2013; 170: 146–51.

  21. Sivaram C.A., Summers J.H., Ahmed N. Telemetry outside critical care units: patterns of utilization and influence on management decisions. Clin. Cardiol. 1998; 21: 503–5.

  22. Ivonye C., Ohuabunwo C., Henriques-Forsythe M. et al. Evaluation of telemetry utilization, policy, and outcomes in an inner-city academic medical center. J. Natl. Med. Assoc. 2010; 102: 598–604.

  23. Johnson P.C., Ammar H., Zohdy W. et al. Yield of diagnostic tests and its impact on cost in adult patients with syncope presenting to a community hospital. South Med. J. 2014; 107: 707–14.

  24. Sclafani J.J., My J., Zacher L.L. et al. Intensive education on evidence-based evaluation of syncope increases sudden death risk stratification but fails to reduce use of neuroimaging. Arch. Intern. Med. 2010; 170: 1150–4.

  25. Epstein A.E., DiMarco J.P., Ellenbogen K.A. et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013; 127: 283–352.

  26. Nishimura R.A., Otto C.M., Bonow R.O. et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: 2440–92.

  27. Zipes D.P., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Circulation. 2006; 114: 1088–132.

  28. Gersh B.J., Maron B.J., Bonow R.O. et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124: 783–831.

  29. Gaita F., Giustetto C., Bianchi F. et al. Short Q–T syndrome: a familial cause of sudden death. Circulation. 2003; 108: 965–70.

  30. De Ferrari G.M., Dusi V., Spazzolini C. et al. Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015; 131: 2185–93.

  31. Mahida S., Derval N., Sacher F. et al. Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome. J. Am. Coll. Cardiol. 2015; 65: 151–9.

  32. Perez-Lugones A., Schweikert R., Pavia S. et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J. Cardiovasc. Electrophysiol. 2001; 12: 935–8.

  33. Samniah N., Sakaguchi S., Lurie K.G. et al. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am. J. Cardiol. 2001; 88: 80–3.

  34. Ward C.R., Gray J.C., Gilroy J.J. et al. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998; 79: 45–9.

  35. Sheldon R.S., Morillo C.A., Klingenheben T. et al. Age-dependent effect of beta-blockers in preventing vasovagal syncope. Circ. Arrhythm. Electrophysiol. 2012; 5: 920–6.

  36. Ammirati F., Colivicchi F., Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001; 104: 52–7.

  37. Brignole M., Menozzi C., Moya A. et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012; 125: 2566–71.

  38. Bockeria O.L., Sergeev A.V. Carotid sinus hypersensitivity. Annaly Aritmologii (Annals of Arrhythmology). 2015; 12 (2): 106–13. DOI: 10. 15275/ annaritmol.2015.2.6 (in Russ.).

About Authors

Berdibekov Bektur Shukurbekovich, Resident Physician, orcid.org/0000-0001-7717-4971

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by